Capcom’s action role-playing game, Dragon’s Dogma 2, has been struggling in terms of sales, even in the presence of discount offers.
According to the Capcom’s updated list of Platinum Titles, a title given to games that have sold more than 1 million copies, the game has sold a total of 200,000 copies during the fourth quarter of 2024, between the period of September 30 and December 31. Meanwhile, Monster Hunter World sold 400,000 copies, and its Iceborne expansion sold 900,000 units during the same period. Additionally, Monster Hunter Rise sold 700,000 copies, and its Sunbreak expansion sold 600,000 units during the quarter.

As such, sales of Dragon’s Dogma 2 have been outpaced by these older Monster Hunter titles and their respective DLCs during Q4 2024, despite it being offered on sale during this period, with discounts of up to 40%.. However, to be fair, Monster Hunter is a long-running and established series with many releases, while Dragon’s Dogma 2 is only the second entry in its series.
A majority of Dragon’s Dogma 2’s lifetime sales of 3.5 million copies were front-loaded, as the game had sold around 3 million in May, 2024, 2 months after its launch. The remaining 0.5 million were sold across the rest of 2024. The action role-playing game is currently being offered at a discount of 40% across the PlayStation Store, the Xbox Store, and Steam, but that doesn’t seem to have changed things, as indicated by it being at #243 on Steam’s global top sellers.
While Dragon’s Dogma 2’s sales are disappointing to a certain extent, it’s worth putting a few things into perspective. The game launched in a rough technical state and hardly received any post-launch content updates or expansions. Despite that, it performed comparably to Capcom’s fighting game, Street Fighter 6, a game that is supported with updates and DLC, in terms of launch-aligned sales. The latter had sold around 3.7 million copies a year after its release. By March, 2025, a year after Dragon’s Dogma 2’s launch, its sales will likely reach a similar figure.